Whalesbook
HUL Confirms Food Business Importance Amid Parent Review
Hindustan Unilever Limited has officially denied rumors of selling its food business, calling it an "important and attractive" part of its operations. This directly addresses speculation about a broad strategic review by parent company Unilever PLC. Unilever is reportedly considering choices, potentially including selling its global food division, as part of a broader goal to focus its portfolio on faster-growing, more profitable areas like beauty, personal care, and wellness. This fits a known industry trend where companies are simplifying slower-growing food categories, which has seen slower growth.
Stock Performance and Valuation Metrics
Despite HUL's denial of selling plans, its stock closed Wednesday, March 25, 2026, up 2.45% at ₹2,136. However, this gain doesn't alter its year-to-date performance, with shares down over 5% in the past year, significantly underperforming the Nifty 50 index's approximate 2% decline. The company's market value is around ₹4.9 trillion. Its trailing 12-month price-to-earnings (P/E) ratio has varied, recently reported between approximately 40.5x and 50.46x, although some reports indicate a lower P/E of 33.69x as of March 24, 2026. This valuation is complex when compared to competitors. ITC trades at a much lower P/E ratio of about 18.19x, while Nestle India has a higher multiple, with its P/E ratio near 70.9x. HUL's P/E, though below Nestle India's, is notably above the industry average P/E of roughly 44.47x, raising questions about its high valuation, especially when compared to its modest revenue growth (around 6.29% over three years) and profit growth (6.47%).
Consumer Trends and Health Drug Impact
The consumer goods sector is seeing major shifts, with packaged food growth slowing, while demand grows for health, wellness, and premium personal care items. A notable disruptive factor is the increasing use of anti-obesity drugs like Ozempic and Wegovy. These medications could lead consumers to spend less on calorie-dense foods, particularly in developed markets. Industry estimates project high single-digit volume growth for the Indian FMCG sector in 2026, driven by premiumization and wellness products. However, the influence of health trends on core food segments remains a key factor to watch.
Concerns About Growth and Strategic Fit
Although HUL has officially denied divestment and many analysts maintain a 'Buy' rating with price targets suggesting upside, several factors suggest caution. HUL's P/E ratio of over 50x seems high compared to ITC's approximately 18x and its own modest historical revenue and profit growth rates. Consistent underperformance against benchmarks like the Sensex, with significant deficits in three-year returns, raises questions about the company's ability to achieve market-beating performance. Furthermore, parent company Unilever's clear move towards beauty and health, shown by selling its ice cream business and discussing its food division with McCormick & Company, indicates that food is becoming less of a priority for the group. This external pressure, combined with fundamental shifts in consumer behavior due to GLP-1 drugs, presents a significant challenge to the growth prospects of HUL's food portfolio. Unilever also faces distractions, including an ongoing investigation by the CMA into its environmental claims, which may divert management attention.
Market Outlook and Analyst Views
Looking ahead, the Indian FMCG market is expected to see steady volume growth in the upper single-digit range, supported by government policies and improving urban demand. Analysts generally remain positive, with average 12-month price targets around ₹2,637.50, suggesting potential upside. However, the strategic review at Unilever and the significant impact of health trends on food consumption introduce a level of uncertainty. While HUL has officially reaffirmed its commitment to its food business, the broader market sentiment and Unilever's actions suggest a challenging environment where its food segment may increasingly be questioned on its long-term strategic role compared to the company's more favored health and beauty segments.